1) Clinical features of immune TTP 2) common clinical scenario
Initial symptoms (fatigue, dyspnea, petechia, abdominal pain/ nausea/vomiting (45%), headache/confusion (20%) - typically mild symptoms at onset) + abnormal or normal (more commonly) kidney function (AKI uncommon), often comorbid autoimmune disorders + typically previously healthy person + median age 40 + females more commonly (75%) + increased frequency in pregnancy
Primary cause of death in TTP
myocardial infarction
Diagnostic cutoff for ADAMTS13 level in TTP
<10%
caplacizumab mechanism
blocks platelet interaction with von willebrand factor
congenital TTP treatment
Screening required for patients with history of TTP